The CRISPR-Cas app goes viral
[Display omitted] •CRISPR spacer content is a gold mine of information to learn about the past genetic environments of microbial populations.•Bacteria of industrial interest can be protected against phages by means of natural or engineered CRISPR immunization.•Natural and engineered CRISPR-Cas syste...
Gespeichert in:
Veröffentlicht in: | Current opinion in microbiology 2017-06, Vol.37, p.103-109 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 109 |
---|---|
container_issue | |
container_start_page | 103 |
container_title | Current opinion in microbiology |
container_volume | 37 |
creator | Lemay, Marie-Laurence Horvath, Philippe Moineau, Sylvain |
description | [Display omitted]
•CRISPR spacer content is a gold mine of information to learn about the past genetic environments of microbial populations.•Bacteria of industrial interest can be protected against phages by means of natural or engineered CRISPR immunization.•Natural and engineered CRISPR-Cas systems can be found on the genome of phages.•A century of phage research and a decade of CRISPR-Cas research provide novel opportunities to fight multi-drug resistant bacteria.
If biology laboratories were smartphones, CRISPR-Cas would be the leading app. Nowadays, technology users rely on apps to communicate, get directions, entertain, and more. Likewise, many life scientists now rely on CRISPR-Cas systems to study the interactions between microbes and their viruses, to track strains as well as to modify and modulate genomes. Considering their high level of polymorphism, CRISPR arrays can increase the resolution of a microbial typing scheme. As dynamic systems, they allow the identification and the tracking of specific sequences, which is highly valuable for epidemiological studies. As a defense mechanism, they offer an opportunity to generate virus-resistant strains or even to construct strains refractory to the acquisition of specific genes. And last but not least, as customizable and transferable tools, CRISPR-Cas systems are particularly promising to fight multi-drug resistant bacteria through the engineering of phages. |
doi_str_mv | 10.1016/j.mib.2017.06.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911201184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1369527417300139</els_id><sourcerecordid>1911201184</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-299f558c07e57161fffff76a9d2bba79c030336741975c25ffeb8e796b0e048a3</originalsourceid><addsrcrecordid>eNp9kU1LAzEQhoMoWj9-gAelRy-7zmx2kw2CIMWPgqDYeg7ZdFZTt92atIX-e7NUPXgwl8nhfV6YZxg7RUgRUFxO05mr0gxQpiBSANxhPSylSoCLfDf-uVBJkcn8gB2GMAWAXBVinx1kpci4RNVjZ-N36g9ehqPnl2RgQt8sFv23lkJ_7bxpjtlebZpAJ9_ziL3e3Y4HD8nj0_1wcPOY2BzKZZIpVRdFaUFSIVFg3T0pjJpkVWWkssCBcyFzVLKwWVHXVJUklaiAIC8NP2IX296Fbz9XFJZ65oKlpjFzaldBo0KMa2KZxyhuo9a3IXiq9cK7mfEbjaA7K3oa4Up3VjQIHa1E5vy7flXNaPJL_GiIgattgOKSa0deB-tobmniPNmlnrTu3_rrP7Rt3NxZ03zQhsK0Xfl5tKdRh0yDHnVn6a6Ckne44l8iZoOS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1911201184</pqid></control><display><type>article</type><title>The CRISPR-Cas app goes viral</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lemay, Marie-Laurence ; Horvath, Philippe ; Moineau, Sylvain</creator><creatorcontrib>Lemay, Marie-Laurence ; Horvath, Philippe ; Moineau, Sylvain</creatorcontrib><description>[Display omitted]
•CRISPR spacer content is a gold mine of information to learn about the past genetic environments of microbial populations.•Bacteria of industrial interest can be protected against phages by means of natural or engineered CRISPR immunization.•Natural and engineered CRISPR-Cas systems can be found on the genome of phages.•A century of phage research and a decade of CRISPR-Cas research provide novel opportunities to fight multi-drug resistant bacteria.
If biology laboratories were smartphones, CRISPR-Cas would be the leading app. Nowadays, technology users rely on apps to communicate, get directions, entertain, and more. Likewise, many life scientists now rely on CRISPR-Cas systems to study the interactions between microbes and their viruses, to track strains as well as to modify and modulate genomes. Considering their high level of polymorphism, CRISPR arrays can increase the resolution of a microbial typing scheme. As dynamic systems, they allow the identification and the tracking of specific sequences, which is highly valuable for epidemiological studies. As a defense mechanism, they offer an opportunity to generate virus-resistant strains or even to construct strains refractory to the acquisition of specific genes. And last but not least, as customizable and transferable tools, CRISPR-Cas systems are particularly promising to fight multi-drug resistant bacteria through the engineering of phages.</description><identifier>ISSN: 1369-5274</identifier><identifier>EISSN: 1879-0364</identifier><identifier>DOI: 10.1016/j.mib.2017.06.001</identifier><identifier>PMID: 28623719</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>CRISPR-Cas Systems ; Gene Editing - methods ; Host-Pathogen Interactions ; Humans ; Molecular Diagnostic Techniques - methods ; Molecular Medicine - methods ; Pathology ; Precision Medicine - methods ; Recombination, Genetic</subject><ispartof>Current opinion in microbiology, 2017-06, Vol.37, p.103-109</ispartof><rights>Elsevier Ltd</rights><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-299f558c07e57161fffff76a9d2bba79c030336741975c25ffeb8e796b0e048a3</citedby><cites>FETCH-LOGICAL-c408t-299f558c07e57161fffff76a9d2bba79c030336741975c25ffeb8e796b0e048a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1369527417300139$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28623719$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lemay, Marie-Laurence</creatorcontrib><creatorcontrib>Horvath, Philippe</creatorcontrib><creatorcontrib>Moineau, Sylvain</creatorcontrib><title>The CRISPR-Cas app goes viral</title><title>Current opinion in microbiology</title><addtitle>Curr Opin Microbiol</addtitle><description>[Display omitted]
•CRISPR spacer content is a gold mine of information to learn about the past genetic environments of microbial populations.•Bacteria of industrial interest can be protected against phages by means of natural or engineered CRISPR immunization.•Natural and engineered CRISPR-Cas systems can be found on the genome of phages.•A century of phage research and a decade of CRISPR-Cas research provide novel opportunities to fight multi-drug resistant bacteria.
If biology laboratories were smartphones, CRISPR-Cas would be the leading app. Nowadays, technology users rely on apps to communicate, get directions, entertain, and more. Likewise, many life scientists now rely on CRISPR-Cas systems to study the interactions between microbes and their viruses, to track strains as well as to modify and modulate genomes. Considering their high level of polymorphism, CRISPR arrays can increase the resolution of a microbial typing scheme. As dynamic systems, they allow the identification and the tracking of specific sequences, which is highly valuable for epidemiological studies. As a defense mechanism, they offer an opportunity to generate virus-resistant strains or even to construct strains refractory to the acquisition of specific genes. And last but not least, as customizable and transferable tools, CRISPR-Cas systems are particularly promising to fight multi-drug resistant bacteria through the engineering of phages.</description><subject>CRISPR-Cas Systems</subject><subject>Gene Editing - methods</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Molecular Diagnostic Techniques - methods</subject><subject>Molecular Medicine - methods</subject><subject>Pathology</subject><subject>Precision Medicine - methods</subject><subject>Recombination, Genetic</subject><issn>1369-5274</issn><issn>1879-0364</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1LAzEQhoMoWj9-gAelRy-7zmx2kw2CIMWPgqDYeg7ZdFZTt92atIX-e7NUPXgwl8nhfV6YZxg7RUgRUFxO05mr0gxQpiBSANxhPSylSoCLfDf-uVBJkcn8gB2GMAWAXBVinx1kpci4RNVjZ-N36g9ehqPnl2RgQt8sFv23lkJ_7bxpjtlebZpAJ9_ziL3e3Y4HD8nj0_1wcPOY2BzKZZIpVRdFaUFSIVFg3T0pjJpkVWWkssCBcyFzVLKwWVHXVJUklaiAIC8NP2IX296Fbz9XFJZ65oKlpjFzaldBo0KMa2KZxyhuo9a3IXiq9cK7mfEbjaA7K3oa4Up3VjQIHa1E5vy7flXNaPJL_GiIgattgOKSa0deB-tobmniPNmlnrTu3_rrP7Rt3NxZ03zQhsK0Xfl5tKdRh0yDHnVn6a6Ckne44l8iZoOS</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Lemay, Marie-Laurence</creator><creator>Horvath, Philippe</creator><creator>Moineau, Sylvain</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>The CRISPR-Cas app goes viral</title><author>Lemay, Marie-Laurence ; Horvath, Philippe ; Moineau, Sylvain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-299f558c07e57161fffff76a9d2bba79c030336741975c25ffeb8e796b0e048a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CRISPR-Cas Systems</topic><topic>Gene Editing - methods</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Molecular Diagnostic Techniques - methods</topic><topic>Molecular Medicine - methods</topic><topic>Pathology</topic><topic>Precision Medicine - methods</topic><topic>Recombination, Genetic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lemay, Marie-Laurence</creatorcontrib><creatorcontrib>Horvath, Philippe</creatorcontrib><creatorcontrib>Moineau, Sylvain</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lemay, Marie-Laurence</au><au>Horvath, Philippe</au><au>Moineau, Sylvain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The CRISPR-Cas app goes viral</atitle><jtitle>Current opinion in microbiology</jtitle><addtitle>Curr Opin Microbiol</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>37</volume><spage>103</spage><epage>109</epage><pages>103-109</pages><issn>1369-5274</issn><eissn>1879-0364</eissn><abstract>[Display omitted]
•CRISPR spacer content is a gold mine of information to learn about the past genetic environments of microbial populations.•Bacteria of industrial interest can be protected against phages by means of natural or engineered CRISPR immunization.•Natural and engineered CRISPR-Cas systems can be found on the genome of phages.•A century of phage research and a decade of CRISPR-Cas research provide novel opportunities to fight multi-drug resistant bacteria.
If biology laboratories were smartphones, CRISPR-Cas would be the leading app. Nowadays, technology users rely on apps to communicate, get directions, entertain, and more. Likewise, many life scientists now rely on CRISPR-Cas systems to study the interactions between microbes and their viruses, to track strains as well as to modify and modulate genomes. Considering their high level of polymorphism, CRISPR arrays can increase the resolution of a microbial typing scheme. As dynamic systems, they allow the identification and the tracking of specific sequences, which is highly valuable for epidemiological studies. As a defense mechanism, they offer an opportunity to generate virus-resistant strains or even to construct strains refractory to the acquisition of specific genes. And last but not least, as customizable and transferable tools, CRISPR-Cas systems are particularly promising to fight multi-drug resistant bacteria through the engineering of phages.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28623719</pmid><doi>10.1016/j.mib.2017.06.001</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1369-5274 |
ispartof | Current opinion in microbiology, 2017-06, Vol.37, p.103-109 |
issn | 1369-5274 1879-0364 |
language | eng |
recordid | cdi_proquest_miscellaneous_1911201184 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | CRISPR-Cas Systems Gene Editing - methods Host-Pathogen Interactions Humans Molecular Diagnostic Techniques - methods Molecular Medicine - methods Pathology Precision Medicine - methods Recombination, Genetic |
title | The CRISPR-Cas app goes viral |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20CRISPR-Cas%20app%20goes%20viral&rft.jtitle=Current%20opinion%20in%20microbiology&rft.au=Lemay,%20Marie-Laurence&rft.date=2017-06-01&rft.volume=37&rft.spage=103&rft.epage=109&rft.pages=103-109&rft.issn=1369-5274&rft.eissn=1879-0364&rft_id=info:doi/10.1016/j.mib.2017.06.001&rft_dat=%3Cproquest_cross%3E1911201184%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1911201184&rft_id=info:pmid/28623719&rft_els_id=S1369527417300139&rfr_iscdi=true |